American Vanguard (AVD) 10-Q 2 Aug 16 2016 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2016	Jul. 22, 2016
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q2
Trading Symbol	AVD
Entity Registrant Name	AMERICAN VANGUARD CORP
Entity Central Index Key	5,981
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		29,348,649

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Net sales	$ 72,724	$ 66,523	$ 142,198	$ 133,088
Cost of sales	41,329	41,402	83,300	83,317
Gross profit	31,395	25,121	58,898	49,771
Operating expenses	26,301	23,922	49,174	48,266
Operating income	5,094	1,199	9,724	1,505
Interest expense	462	662	1,003	1,303
Income before provision for income taxes and loss on equity investment	4,632	537	8,721	202
Income taxes expense (benefit)	1,203	(393)	2,263	(685)
Income before loss on equity investment	3,429	930	6,458	887
Less net loss from equity investment	(47)	(191)	(129)	(191)
Net income	3,382	739	6,329	696
Add back net loss (income) attributable to non-controlling interest	(136)	42	(289)	136
Net income attributable to American Vanguard	$ 3,246	$ 781	$ 6,040	$ 832
Earnings per common share-basic	$ 0.11	$ 0.03	$ 0.21	$ 0.03
Earnings per common share-assuming dilution	$ 0.11	$ 0.03	$ 0.21	$ 0.03
Weighted average shares outstanding-basic	28,893	28,676	28,851	28,602
Weighted average shares outstanding-assuming dilution	29,377	29,202	29,342	29,103

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 5,799	$ 5,524
Receivables:
Trade, net of allowance for doubtful accounts of $363 and $423, respectively	76,151	72,835
Other	3,394	2,554
Total receivables	79,545	75,389
Inventories	151,102	136,477
Prepaid expenses	13,979	11,172
Income taxes receivable		168
Deferred income tax assets	8,101	8,101
Total current assets	258,526	236,831
Property, plant and equipment, net	45,388	47,972
Intangible assets, net of applicable amortization	125,410	129,160
Other assets	30,331	29,576
Total assets	459,655	443,539
Current liabilities:
Current installments of other notes payable	18	55
Current installments of other liabilities	138	514
Accounts payable	25,180	15,343
Deferred revenue	6,956	8,888
Accrued program costs	62,327	44,371
Accrued expenses and other payables	9,012	7,111
Income taxes payable	1,029
Total current liabilities	104,660	76,282
Long-term debt and other notes payable, excluding current installments	49,576	68,321
Other liabilities, excluding current installments	3,029	3,054
Deferred income tax liabilities	27,556	27,556
Total liabilities	184,821	175,213
Commitments and contingent liabilities
Stockholders' equity:
Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued
Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 31,788,644 shares at June 30, 2016 and 31,638,225 shares at December 31, 2015	3,180	3,164
Additional paid-in capital	69,438	68,534
Accumulated other comprehensive loss	(3,993)	(3,541)
Retained earnings	214,258	208,507
Total stockholders' equity including treasury stock	282,883	276,664
Less treasury stock, at cost, 2,450,634 shares at June 30, 2016 and December 31, 2015	(8,269)	(8,269)
American Vanguard Corporation stockholders' equity	274,614	268,395
Non-controlling interest	220	(69)
Total stockholders' equity	274,834	268,326
Total liabilities and stockholders' equity	$ 459,655	$ 443,539

CONDENSED CONSOLIDATED BALANCE4

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Allowance for doubtful accounts	$ 363	$ 423
Preferred stock, par value per share	$ 0.10	$ 0.10
Preferred stock, shares authorized	400,000	400,000
Preferred stock, shares issued	0	0
Common stock, par value per share	$ 0.10	$ 0.10
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	31,788,644	31,638,225
Treasury stock, shares	2,450,634	2,450,634

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income/(loss)	Retained Earnings	Treasury Stock	AVD Total	Non- Controlling Interest
Balance at Dec. 31, 2014				$ (1,970)
Foreign currency translation adjustment, net	$ (571)
Net (loss) income	696
Balance at Jun. 30, 2015				(2,541)
Balance at Mar. 31, 2015				(2,218)
Foreign currency translation adjustment, net	(323)
Net (loss) income	$ 739
Balance at Jun. 30, 2015				(2,541)
Balance (in shares) at Dec. 31, 2015	31,638,225	31,638,225				2,450,634
Balance at Dec. 31, 2015	$ 268,326	$ 3,164	$ 68,534	(3,541)	$ 208,507	$ (8,269)	$ 268,395	$ (69)
Stocks issued under ESPP (in shares)		19,627
Stocks issued under ESPP	271	$ 2	269				271
Foreign currency translation adjustment, net	85			85			85
Stock based compensation	456		456				456
Stock options exercised and grants and vesting of restricted stock units	(586)	$ (6)	(580)				(586)
Stock options exercised and grants and vesting of restricted stock units, Shares		61,550
Excess tax benefits from share based payment arrangements	35		35				35
Net (loss) income	2,947				2,794		2,794	153
Balance (in shares) at Mar. 31, 2016		31,596,302				2,450,634
Balance at Mar. 31, 2016	$ 271,534	$ 3,160	68,714	(3,456)	211,301	$ (8,269)	271,450	84
Balance (in shares) at Dec. 31, 2015	31,638,225	31,638,225				2,450,634
Balance at Dec. 31, 2015	$ 268,326	$ 3,164	68,534	(3,541)	208,507	$ (8,269)	268,395	(69)
Foreign currency translation adjustment, net	(452)
Net (loss) income	$ 6,329
Balance (in shares) at Jun. 30, 2016	31,788,644	31,788,644				2,450,634
Balance at Jun. 30, 2016	$ 274,834	$ 3,180	69,438	(3,993)	214,258	$ (8,269)	274,614	220
Balance (in shares) at Mar. 31, 2016		31,596,302				2,450,634
Balance at Mar. 31, 2016	271,534	$ 3,160	68,714	(3,456)	211,301	$ (8,269)	271,450	84
Cash dividends on common stock ($0.01 per share)	(289)				(289)		(289)
Foreign currency translation adjustment, net	(537)			(537)			(537)
Stock based compensation	612		612				612
Stock options exercised and grants and vesting of restricted stock units	120	$ 20	100				120
Stock options exercised and grants and vesting of restricted stock units, Shares		192,342
Excess tax benefits from share based payment arrangements	12		12				12
Net (loss) income	$ 3,382				3,246		3,246	136
Balance (in shares) at Jun. 30, 2016	31,788,644	31,788,644				2,450,634
Balance at Jun. 30, 2016	$ 274,834	$ 3,180	$ 69,438	$ (3,993)	$ 214,258	$ (8,269)	$ 274,614	$ 220

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)	3 Months Ended
	Jun. 30, 2016$ / shares
Cash dividends on common stock, per share	$ 0.01

CONDENSED CONSOLIDATED STATEME7

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Net income attributable to American Vanguard	$ 3,246	$ 781	$ 6,040	$ 832
Foreign currency translation adjustment	(537)	(323)	(452)	(571)
Comprehensive income	$ 2,709	$ 458	$ 5,588	$ 261

CONDENSED CONSOLIDATED STATEME8

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities:
Net income	$ 6,329	$ 696
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of fixed and intangible assets	8,359	7,864
Amortization of other long term assets	2,358	2,734
Amortization of discounted liabilities	19	154
Stock-based compensation	1,068	2,485
Tax benefit from exercise of stock options	(47)	(7)
Operating loss from equity investment	129	191
Changes in assets and liabilities associated with operations:
(Increase) decrease in net receivables	(4,156)	8,975
(Increase) decrease in inventories	(14,625)	397
(Increase) decrease in prepaid expenses and other assets	(2,661)	143
Decrease (increase) in income tax receivable/payable, net	1,244	(878)
Increase (decrease) in accounts payable	9,837	(392)
(Decrease) increase in deferred revenue	(1,932)	3,611
Increase in program payables	17,956	17,057
Increase in other payables and accrued expenses	1,612	794
Net cash provided by operating activities	25,490	43,824
Cash flows from investing activities:
Capital expenditures	(1,729)	(3,480)
Investment	(3,283)	(125)
Acquisitions of product lines and other intangible assets	(224)	(36,435)
Net cash used in investing activities	(5,236)	(40,040)
Cash flows from financing activities:
Net payments under line of credit agreement	(18,850)	(11,120)
Increase in other notes payable		10,000
Payments on other long-term liabilities	(457)	(899)
Tax benefit from exercise of stock options	47	7
Payment of cash dividends		(1,141)
Net proceeds from sale of stock under ESPP and exercise of stock options	(195)	(40)
Net cash used in financing activities	(19,455)	(3,193)
Net increase in cash and cash equivalents	799	591
Cash and cash equivalents at beginning of period	5,524	4,885
Effect of exchange rate changes on cash	(524)	(387)
Cash and cash equivalents at end of period	$ 5,799	$ 5,089

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2016
Summary of Significant Accounting Policies	1. The accompanying unaudited condensed consolidated financial statements of American Vanguard Corporation and Subsidiaries (“AVD”) have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation, have been included. Operating results for the six months ended June 30, 2016 are not necessarily indicative of the results that may be expected for the year ending December 31, 2016. For further information, refer to the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.

Property, Plant and Equipment

Property, Plant and Equipment	6 Months Ended
	Jun. 30, 2016
Property, Plant and Equipment	2. Property, plant and equipment at June 30, 2016 and December 31, 2015 consists of the following: June 30, 2016 December 31, 2015 Land $ 2,458 $ 2,458 Buildings and improvements 15,020 14,726 Machinery and equipment 116,928 113,506 Office furniture, fixtures and equipment 4,947 4,997 Automotive equipment 508 491 Construction in progress 1,334 3,413 141,195 139,591 Less accumulated depreciation (95,807 ) (91,619 ) $ 45,388 $ 47,972 The Company recognized depreciation expense related to property, plant and equipment of $4,313 and $4,531 for the six months ended June 30, 2016 and 2015, respectively. During the six months ended June 30, 2016 and 2015, the Company eliminated from assets and accumulated depreciation $125 and $231, respectively, of fully depreciated assets. Substantially all of the Company’s assets are pledged as collateral with its banks.

Inventories

Inventories	6 Months Ended
	Jun. 30, 2016
Inventories	3. Inventories are stated at the lower of cost or market. Cost is determined using the first-in, first-out method. The components of inventories consist of the following: June 30, 2016 December 31, 2015 Finished products $ 131,946 $ 120,456 Raw materials 19,156 16,021 $ 151,102 $ 136,477

Segment Reporting

Segment Reporting	6 Months Ended
	Jun. 30, 2016
Segment Reporting	4. Based on similar economic and operational characteristics, the Company’s business is aggregated into one reportable segment. Selective enterprise information is as follows: Three Months Ended June 30 Six Months Ended June 30 2016 2015 2016 2015 Net sales: Insecticides $ 30,912 $ 27,586 $ 64,018 $ 61,945 Herbicides/soil fumigants/fungicides 21,093 17,451 45,767 39,291 Other, including plant growth regulators 6,331 12,755 9,820 16,077 58,336 57,792 119,605 117,313 Non-crop 14,388 8,731 22,593 15,775 $ 72,724 $ 66,523 $ 142,198 $ 133,088 Three Months Ended June 30 Six Months Ended June 30 2016 2015 2016 2015 Net sales: US $ 51,773 $ 43,842 $ 101,628 $ 93,064 International 20,951 22,681 40,570 40,024 $ 72,724 $ 66,523 $ 142,198 $ 133,088

Accrued Program Costs

Accrued Program Costs	6 Months Ended
	Jun. 30, 2016
Accrued Program Costs	5. Accrued Program Costs

Cash Dividend

Cash Dividend	6 Months Ended
	Jun. 30, 2016
Cash Dividend	6. The Company has declared and paid in prior periods the following cash dividends in the periods covered by this Form 10-Q: Declaration Date Record Date Distribution Date Dividend Per Share Total Paid June 13, 2016 June 30, 2016 July 12, 2016 $0.01 $289 March 16, 2015 April 3, 2015 April 17, 2015 $0.02 $572 December 11, 2014 December 26, 2014 January 9, 2015 $0.02 $569

Earnings Per Share

Earnings Per Share	6 Months Ended
	Jun. 30, 2016
Earnings Per Share	7. ASC 260 Earnings Per Share (“EPS” The components of basic and diluted earnings per share were as follows: Three Months Ended June 30 Six Months Ended June 30 2016 2015 2016 2015 Numerator: Net income attributable to AVD $ 3,246 $ 781 $ 6,040 $ 832 Denominator: Weighted average shares outstanding-basic 28,893 28,676 28,851 28,602 Dilutive effect of stock options and grants 484 526 491 501 29,377 29,202 29,342 29,103 For the three months and six months ended June 30, 2016 and June 30, 2015, no stock options were excluded from the computation of diluted earnings per share.

Indebtedness

Indebtedness	6 Months Ended
	Jun. 30, 2016
Indebtedness	8. The Company has a revolving line of credit and various notes payable that together constitute the short-term and long-term loan balances shown in the condensed consolidated balance sheets at June 30, 2016 and December 31, 2015. These are summarized in the following table: Indebtedness June 30, 2016 December 31, 2015 $000’s Long- term Short- term Total Long- term Short- term Total Revolving line of credit $ 50,150 $ — $ 50,150 $ 69,000 $ — $ 69,000 Deferred loan fees (574 ) — (574 ) (679 ) — (679 ) Notes payable — 18 18 — 55 55 Total indebtedness $ 49,576 $ 18 $ 49,594 $ 68,321 $ 55 $ 68,376 AMVAC Chemical Corporation (“AMVAC”), the Company’s principal operating subsidiary, as borrower, and affiliates (including the Company), as guarantors and/or borrowers, are parties to a credit agreement dated as of July 11, 2014 (the “Credit Agreement”) with a group of commercial lenders led by Bank of the West (AMVAC’s primary bank) as agent, swing line lender and Letter of Credit (“LC”) issuer. The Credit Agreement is a senior secured lending facility with a five year term and consisting of a revolving line of credit of $200 million and an accordion feature for up to $100 million. The Credit Agreement includes both AMVAC CV (“AMVAC CV”) and AMVAC Netherlands BV (“AMVAC BV”) as borrowers. Under the Credit Agreement, revolving loans bear interest at a variable rate based, at borrower’s election with proper notice, on either (i) LIBOR plus the “Applicable Rate” which is based upon the Consolidated Funded Debt Ratio (“Eurocurrency Rate Loan”) or (ii) the greater of (x) the Prime Rate, (y) the Federal Funds Rate plus 0.5%, and (z) the Daily One-Month LIBOR Rate plus 1.00%, plus, in the case of (x), (y) or (z) the Applicable Rate (“Alternate Base Rate Loan”). Interest payments for Eurocurrency Rate Loans are payable on the last day of each interest period (either one, two, three or six months, as selected by the borrower) and the maturity date, while interest payments for Alternate Base Rate Loans are payable on the last business day of each month and the maturity date. The senior secured revolving line of credit matures on June 17, 2018. Under the Credit Agreement, the Company has three key covenants (with which it was in compliance throughout the six months ended June 30, 2016). The covenants are as follows: (1) the Company must maintain its borrowings below a certain consolidated funded debt ratio, (2) the Company has a limitation on its annual spending on the acquisition of fixed asset capital additions, and (3) the Company must maintain a certain consolidated fixed charge coverage ratio. On April 14, 2015, AMVAC, registrant’s principal operating subsidiary, as borrower, and affiliates (including registrant), as guarantors and/or borrowers, entered into an amendment to the Credit Agreement under which, the Consolidated Funded Debt Ratio was increased for the second, third and fourth quarters of 2015 (to 3.5-to-1 from 3.25-to-1) and a fixed charge covenant, requiring, in effect, that the ratio of consolidated current assets to consolidated current liabilities exceed 1.2-to-1 for the duration of the term of the credit facility, was added. At June 30, 2016, based on its performance against the most restrictive covenants listed above, the Company had the capacity to increase its borrowings by up to $92,588, according to the terms of the Credit Agreement. This compares to an available borrowing capacity of $27,101 as of June 30, 2015. The increased level of borrowing capacity is driven by three factors: (1) our financial performance, as measured in EBITDA for the trailing twelve month period, has improved, (2) borrowings have decreased compared to the second quarter of 2015, when the Company had borrowed from the credit facility to fund two product line acquisitions, and (3) the leverage covenant (being the number of times EBITDA the Company may borrow under its credit facility agreement) is lower when compared with the earlier period.

Reclassification

Reclassification	6 Months Ended
	Jun. 30, 2016
Reclassification	9. Reclassification—Certain items may have been reclassified in the prior period condensed consolidated financial statements to conform with the June 30, 2016 presentation.

Comprehensive income

Comprehensive income	6 Months Ended
	Jun. 30, 2016
Comprehensive income	10. Total comprehensive income includes, in addition to net income, changes in equity that are excluded from the condensed consolidated statements of operations and are recorded directly into a separate section of stockholders’ equity on the condensed consolidated balance sheets. For the three month and six month periods ended June 30, 2016, total comprehensive income consisted of net income attributable to American Vanguard and foreign currency translation adjustments.

Stock Based Compensation

Stock Based Compensation	6 Months Ended
	Jun. 30, 2016
Stock Based Compensation	11. Stock Based Compensation—The Company accounts for stock-based awards to employees and directors in accordance with FASB ASC 718, “ Share-Based Payment The below tables illustrate the Company’s stock based compensation, unamortized stock-based compensation, and remaining weighted average period for the three months and six months ended June 30, 2016 and 2015. Stock-Based Stock-Based Unamortized Remaining June 30, 2016 Incentive Stock Options $ 92 $ 181 $ 627 1.5 Restricted Stock 368 694 3,119 2.0 Performance Based Restricted Stock 107 140 1,079 2.8 Performance Based Options 45 53 226 1.5 Total $ 612 $ 1,068 $ 5,051 June 30, 2015 Incentive Stock Options $ 116 $ 231 $ 1,204 2.5 Restricted Stock 790 1,962 3,521 1.5 Performance Based Restricted Stock 107 205 811 2.0 Performance Based Options 45 87 454 2.5 Total $ 1,058 $ 2,485 $ 5,990 Stock Options—During the six months ended June 30, 2016, the Company did not grant any employees options to acquire shares of common stock. Option activity within each plan is as follows: Incentive Weighted Average Exercisable Balance outstanding, December 31, 2015 626,845 $ 9.25 $ 7.73 Options exercised (25,500 ) 7.50 Options forfeited (9,813 ) 11.49 Balance outstanding, March 31, 2016 591,532 $ 9.29 $ 7.84 Options exercised (12,900 ) 7.50 Options forfeited (5,000 ) 11.49 Balance outstanding, June 30, 2016 573,632 $ 9.31 $ 7.85 Information relating to stock options at June 30, 2016 summarized by exercise price is as follows: Outstanding Weighted Average Exercisable Weighted Exercise Price Per Share Shares Remaining Exercise Shares Exercise Incentive Stock Option Plan: $7.50 318,850 53 $ 7.50 318,850 $ 7.50 $11.32—$14.49 254,782 98 $ 11.57 25,507 $ 12.28 573,632 $ 9.31 344,357 $ 7.85 The weighted average exercise prices for options granted and exercisable and the weighted average remaining contractual life for options outstanding as of June 30, 2016 was as follows: Number Weighted Weighted Intrinsic As of June 30, 2016: Incentive Stock Option Plans: Outstanding 573,632 $ 9.31 73 $ 3,329 Expected to Vest 565,767 $ 9.28 73 $ 3,300 Exercisable 344,357 $ 7.85 54 $ 2,499 During the three months ended June 30, 2016 and 2015, the Company recognized stock-based compensation related to stock options of $92 and $116, respectively. During the six months ended June 30, 2016 and 2015, the Company recognized stock-based compensation related to stock options of $181 and $231, respectively. As of June 30, 2016, the Company had approximately $627 of unamortized stock-based compensation related to unvested stock options outstanding. This amount will be recognized over the weighted-average period of 1.5 years. This projected expense will change if any stock options are granted or cancelled prior to the respective reporting periods or if there are any changes required to be made for estimated forfeitures. Restricted Shares — Six Months Ended Six Months Ended Number Weighted Number Weighted Nonvested shares at January 1 st 362,841 $ 20.43 560,842 $ 21.44 Granted — — 30,000 11.42 Vested (127,274 ) 31.29 (192,266 ) 20.47 Forfeited (16,008 ) 23.67 (422 ) 14.92 Nonvested shares at March 31 st 219,559 $ 14.59 398,154 $ 21.17 Granted 140,541 $ 15.08 21,005 $ 14.28 Vested (22,639 ) 15.63 (28,505 ) 13.53 Forfeited (6,457 ) 14.98 (1,201 ) 14.92 Nonvested shares at June 30 th 331,004 $ 14.72 389,453 $ 21.37 Restricted Shares—During the six months ended June 30, 2016, the Company granted a total of 140,541 shares of restricted common stock to employees. Of these, 21,139 shares vested immediately and the remaining 119,402 shares will cliff vest after three years of service. The shares granted in 2016 were average fair valued at $15.08 per share. The fair value was determined by using the publicly traded share price as of the date of grant. The Company is recognizing as expense the value of restricted shares over the required service period. During the six months ended June 30, 2015, the Company granted a total of 51,005 shares of common stock. Of these, 21,005 shares vest immediately, 7,500 shares will vest after 90 days and the balance will cliff vest after three years of service. The shares granted in 2015 were average fair valued at $12.60 per share. The fair value was determined by using the publicly traded share price as of the date of grant. The Company is recognizing as expense the value of restricted shares over the required service period. During the three months ended June 30, 2016 and 2015, the Company recognized stock-based compensation related to restricted shares of $368 and $790, respectively. During the six months ended June 30, 2016 and 2015, the Company recognized stock-based compensation related to restricted shares of $694 and $1,962, respectively. As of June 30, 2016, the Company had approximately $3,119 of unamortized stock-based compensation related to unvested restricted shares. This amount will be recognized over the weighted-average period of 2.0 years. This projected expense will change if any restricted shares are granted or cancelled prior to the respective reporting periods or if there are any changes required to be made for estimated forfeitures. Performance Based Restricted Shares — Six Months Ended Six Months Ended Number Weighted Number Weighted Nonvested shares at January 1 st 104,403 $ 17.05 103,907 $ 17.77 Granted — — 7,500 10.96 Forfeited (9,395 ) 17.65 — — Nonvested shares at March 31 st 95,008 $ 16.99 111,407 $ 17.31 Granted 52,170 14.39 — — Forfeited (19,612 ) 28.25 — — Nonvested shares at June 30 th 127,566 $ 14.20 111,407 $ 17.31 Performance Based Shares—During the six months ended June 30, 2016, the Company granted a total of 52,170 performance based shares that will cliff vest on January 6, 2019, provided that the recipients are individually continuously employed by the Company during the vesting period. These shares have a measurement period commencing January 1, 2016 and ending December 31, 2018. Eighty percent of these performance based shares are based upon the financial performance of the Company, specifically, an earnings before income tax (“EBIT”) goal weighted at 50% and a net sales goal weighted at 30%. The remaining 20% of performance based shares are based upon AVD stock price appreciation over the same performance measurement period. The EBIT and net sales goals measure the relative growth of the Company’s EBIT and net sales for the performance measurement period, as compared to the median growth of EBIT and net sales for an identified peer group. The stockholder return goal measures the relative growth of the fair market value of the Company’s stock price over the performance measurement period, as compared to that of the Russell 2000 Index and the median fair market value of the common stock of the comparator companies, identified in the Company’s 2015 Proxy Statement. All parts of these awards vest in three years, but are subject to reduction to a minimum (or even zero) for meeting less than the targeted performance and to increase to a maximum of 200% for meeting in excess of the targeted performance. During the six months ended June 30, 2015, the Company granted a total of 7,500 performance based shares that will cliff vest on January 5, 2018, provided that the recipient is continuously employed by the Company during the vesting period. Eighty percent of these performance based shares are based upon financial performance of the Company, specifically, an earnings before income tax (“EBIT”) goal weighted at 50% and a net sales goal weighted at 30% for the period commencing January 1, 2015 and ending December 31, 2017. The remaining 20% of performance based shares are based upon AVD stock price appreciation over the same performance measurement period. The EBIT and net sales goals measure the relative growth of the Company’s EBIT and net sales for the performance measurement period, as compared to the median growth of EBIT and net sales for an identified peer group. The stockholder return goal measures the relative growth of the fair market value of the Company’s stock price over the performance measurement period, as compared to that of the Russell 2000 Index and the median fair market value of the common stock of the comparator companies, identified in the Company’s 2014 Proxy Statement. All parts of these awards vest in three years, but are subject to reduction to a minimum (or even zero) for meeting less than the targeted performance and to increase to a maximum of 200% for meeting in excess of the targeted performance. As of June 30, 2016, performance based shares related to net income and net sales have an average fair value of $15.08 per share. The fair value was determined by using the publicly traded share price as of the date of grant. The performance based shares related to the Company’s stock price have an average fair value of $11.63 per share. The fair value was determined by using the Monte Carlo valuation method. For awards with performance conditions, the Company recognizes share-based compensation cost on a straight-line basis for each performance criteria over the implied service period when the Company believes it is probable that the performance targets, as defined in the agreements, will be achieved. During the three months ended June 30, 2016 and 2015, the Company recognized stock-based compensation related to performance based shares of $107 and $107, respectively. During the six months ended June 30, 2016 and 2015, the Company recognized stock-based compensation related to performance based shares of $140 and $205, respectively. As of June 30, 2016 the Company had approximately $1,079 of unamortized stock-based compensation related to unvested performance based shares. This amount will be recognized over the weighted-average period of 2.8 years. This projected expense will change if any performance based shares are granted or cancelled prior to the respective reporting periods or if there are any changes required to be made for estimated forfeitures. Performance Based Stock Options—During the six months ended June 30, 2016 and 2015, the Company did not grant any employees performance incentive stock options to acquire shares of common stock. Performance based option activity is as follows: Incentive Weighted Average Exercisable Balance outstanding, December 31, 2015 98,410 $ 11.49 $ — Options forfeited (8,946 ) 11.49 — Balance outstanding, March 31, 2016 89,464 $ 11.49 $ — Balance outstanding, June 30, 2016 89,464 $ 11.49 $ — Information relating to outstanding stock options at June 30, 2016 summarized by exercise price is as follows: Outstanding Weighted Average Exercisable Weighted Exercise Price Per Share Shares Remaining Exercise Shares Exercise Performance Incentive Stock Option Plan: $11.49 89,464 18 $ 11.49 — $ — 89,464 $ 11.49 — $ — The weighted average exercise prices for options granted and exercisable and the weighted average remaining contractual life for options outstanding as of June 30, 2016 are as follows: Number Weighted Weighted Intrinsic As of June 30, 2016: Incentive Stock Option Plans: Outstanding 89,464 $ 11.49 18 $ 324 Expected to Vest 81,546 $ 11.49 18 $ 295 Exercisable — $ — — $ — During the three months ended June 30, 2016 and 2015, the Company recognized stock-based compensation related to performance stock options of $45 and $45, respectively. During the six months ended June 30, 2016 and 2015 the Company recognized stock-based compensation related to performance stock options of $53 and $87, respectively. As of June 30, 2016, the Company had approximately $226 of unamortized stock-based compensation related to unvested performance incentive stock options outstanding. This amount will be recognized over the weighted-average period of 1.5 years. This projected expense will change if any performance incentive stock options are granted or cancelled prior to the respective reporting periods or if there are any changes required to be made for estimated forfeitures.

Legal Proceedings

Legal Proceedings	6 Months Ended
	Jun. 30, 2016
Legal Proceedings	12. Legal proceedings—During the reporting period, there have been no material developments in the legal proceedings that were reported in the Company’s Form 10-K for the period ended December 31, 2015, other than as discussed below: U.S. EPA RCRA/FIFRA Matter Galvan v. AMVAC Graciela Galvan v. AMVAC Chemical Corp. Navarro v. AMVAC Schiemer Farms v. AMVAC Harold Reed v. AMVAC et al.

Recently Issued Accounting Guid

Recently Issued Accounting Guidance	6 Months Ended
	Jun. 30, 2016
Recently Issued Accounting Guidance	13. Recently Issued Accounting Guidance—In March 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-09, Compensation—Stock Compensation (Topic 718) In March 2016, FASB issued ASU 2016-07, Investments—Equity Method and Joint Ventures In February 2016, FASB issued ASU 2016-02, Leases In January 2016, FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities In November 2015, FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes. In July 2015, FASB issued ASU 2015-11, Inventory (Topic 330) In August 2014, FASB issued ASU 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. In May 2014, FASB issued ASU 2014-09, Revenue from Contracts with Customers

Fair Value of Financial Instrum

Fair Value of Financial Instruments	6 Months Ended
	Jun. 30, 2016
Fair Value of Financial Instruments	14. Fair Value of Financial Instruments—The carrying values of cash, receivables and accounts payable approximate their fair values because of the short maturity of these instruments. The fair value of the Company’s long-term debt and note payable to bank is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to the Company for debt of the same remaining maturities. Such fair value approximates the respective carrying values of the Company’s long-term debt and note payable to bank.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income ("AOCI")	6 Months Ended
	Jun. 30, 2016
Accumulated Other Comprehensive Income ("AOCI")	15. Accumulated Other Comprehensive Income (“AOCI”) — The following table lists the beginning balance, annual activity and ending balance of accumulated other comprehensive gain (loss), which consists of foreign currency translation adjustments: For the Six Months Ended June 30, 2016 Balance, December 31, 2015 $ (3,541 ) Other comprehensive gain 85 Balance, March 31, 2016 $ (3,456 ) Other comprehensive loss (537 ) Balance, June 30, 2016 $ (3,993 ) For the Six Months Ended June 30, 2015 Balance, December 31, 2014 $ (1,970 ) Other comprehensive loss (248 ) Balance, March 31, 2015 $ (2,218 ) Other comprehensive loss (323 ) Balance, June 30, 2015 $ (2,541 )

Equity Investment

Equity Investment	6 Months Ended
	Jun. 30, 2016
Equity Investment	16. The Company utilizes the equity method of accounting with respect to its investment in TyraTech Inc. (“TyraTech”), a Delaware corporation that specializes in developing, marketing and selling pesticide products containing natural oils. As of June 30, 2016, the Company’s ownership position in TyraTech was approximately 15.11%. The Company utilizes the equity method of accounting with respect to this investment. As a result, our net income includes losses from this equity method investment, which represents our proportionate share of TyraTech’s estimated net losses for the current accounting period. For the three and six months ended June 30, 2016, the Company recognized a loss of $47 and $129, respectively. For the three and six months ended June 30, 2015, the Company recognized a loss of $191. The Company’s investment in TyraTech is included in other assets on the condensed consolidated balance sheets. At June 30, 2016, the carrying value of the Company’s investment in TyraTech was $2,407 and the quoted market value of its shareholding was $2,324 based on the London Stock Exchange, Alternative Investment Market (“AIM”). At June 30, 2016, the Company performed an impairment review of its investment in TyraTech and concluded that no impairment charge was appropriate.
Biological Products For Agriculture
Equity Investment	17. In February 2016, the Company made an equity investment in Biological Products for Agriculture (“Bi-PA”) through its Netherlands wholly-owned subsidiary. Bi-PA develops biological plant protection products that can be used for the control of pests and disease of agricultural crops. As of June 30, 2016, the Company’s ownership position in Bi-PA was 15%. The Company utilizes the cost method of accounting with respect to this investment and will periodically review the investment for possible impairment. There was no impairment on the investment as of June 30, 2016. The investment is recorded within other assets on the condensed consolidated balance sheets.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2016
Income Taxes	18. Income Taxes—Income tax expense was $2,263 for the six months ended June 30, 2016, as compared to an income tax benefit of $685 for the six months ended June 30, 2015. The effective tax rate was 25.9% (which was a tax expense) in 2016 and 339.1% (which was a tax benefit) in 2015. The effective tax rate for the six months ended June 30, 2016 is based on the projected income for the full year and is subject to ongoing review and adjustment by management. The Company’s Federal income tax returns for the years December 31, 2012 through December 31, 2014 are under examination by the Internal Revenue Service (“IRS”). The results of the audit are not determinable since the audit is still in its initial phase.

Subsequent Event

Subsequent Event	6 Months Ended
	Jun. 30, 2016
Subsequent Event	19. Subsequent Event—On August 2, 2016, the Company’s Netherlands-based subsidiary, AMVAC Netherlands BV, entered into a joint venture with China-based Huifeng Agrochemical Company, Ltd. The new entity, named Huifeng/AMVAC Innovation Co., Ltd., is based in Hong Kong and is intended to focus on activities such as market access and technology transfer between the two members. AMVAC BV is a 50% owner of the new entity. During the entity’s first year, the Managing Director of AMVAC’s Singapore subsidiary will serve as CEO for the venture.

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	6 Months Ended
	Jun. 30, 2016
Summary of Property, Plant and Equipment	Property, plant and equipment at June 30, 2016 and December 31, 2015 consists of the following: June 30, 2016 December 31, 2015 Land $ 2,458 $ 2,458 Buildings and improvements 15,020 14,726 Machinery and equipment 116,928 113,506 Office furniture, fixtures and equipment 4,947 4,997 Automotive equipment 508 491 Construction in progress 1,334 3,413 141,195 139,591 Less accumulated depreciation (95,807 ) (91,619 ) $ 45,388 $ 47,972

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Jun. 30, 2016
Components of Inventories	The components of inventories consist of the following: June 30, 2016 December 31, 2015 Finished products $ 131,946 $ 120,456 Raw materials 19,156 16,021 $ 151,102 $ 136,477

Segment Reporting (Tables)

Segment Reporting (Tables)	6 Months Ended
	Jun. 30, 2016
Summary of Business Sales Segmentation	Selective enterprise information is as follows: Three Months Ended June 30 Six Months Ended June 30 2016 2015 2016 2015 Net sales: Insecticides $ 30,912 $ 27,586 $ 64,018 $ 61,945 Herbicides/soil fumigants/fungicides 21,093 17,451 45,767 39,291 Other, including plant growth regulators 6,331 12,755 9,820 16,077 58,336 57,792 119,605 117,313 Non-crop 14,388 8,731 22,593 15,775 $ 72,724 $ 66,523 $ 142,198 $ 133,088 Three Months Ended June 30 Six Months Ended June 30 2016 2015 2016 2015 Net sales: US $ 51,773 $ 43,842 $ 101,628 $ 93,064 International 20,951 22,681 40,570 40,024 $ 72,724 $ 66,523 $ 142,198 $ 133,088

Cash Dividend (Tables)

Cash Dividend (Tables)	6 Months Ended
	Jun. 30, 2016
Cash Dividend	The Company has declared and paid in prior periods the following cash dividends in the periods covered by this Form 10-Q: Declaration Date Record Date Distribution Date Dividend Per Share Total Paid June 13, 2016 June 30, 2016 July 12, 2016 $0.01 $289 March 16, 2015 April 3, 2015 April 17, 2015 $0.02 $572 December 11, 2014 December 26, 2014 January 9, 2015 $0.02 $569

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2016
Components of Basic and Diluted Earnings Per Share	The components of basic and diluted earnings per share were as follows: Three Months Ended June 30 Six Months Ended June 30 2016 2015 2016 2015 Numerator: Net income attributable to AVD $ 3,246 $ 781 $ 6,040 $ 832 Denominator: Weighted average shares outstanding-basic 28,893 28,676 28,851 28,602 Dilutive effect of stock options and grants 484 526 491 501 29,377 29,202 29,342 29,103

Indebtedness (Tables)

Indebtedness (Tables)	6 Months Ended
	Jun. 30, 2016
Summary of Short-Term and Long-Term Loan Balances in Condensed Consolidated Balance Sheets	The Company has a revolving line of credit and various notes payable that together constitute the short-term and long-term loan balances shown in the condensed consolidated balance sheets at June 30, 2016 and December 31, 2015. These are summarized in the following table: Indebtedness June 30, 2016 December 31, 2015 $000’s Long- term Short- term Total Long- term Short- term Total Revolving line of credit $ 50,150 $ — $ 50,150 $ 69,000 $ — $ 69,000 Deferred loan fees (574 ) — (574 ) (679 ) — (679 ) Notes payable — 18 18 — 55 55 Total indebtedness $ 49,576 $ 18 $ 49,594 $ 68,321 $ 55 $ 68,376

Stock Based Compensation (Table

Stock Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2016
Stock Based Compensation, Unamortized Stock-Based Compensation and Remaining Weighted Average Period	The below tables illustrate the Company’s stock based compensation, unamortized stock-based compensation, and remaining weighted average period for the three months and six months ended June 30, 2016 and 2015. Stock-Based Stock-Based Unamortized Remaining June 30, 2016 Incentive Stock Options $ 92 $ 181 $ 627 1.5 Restricted Stock 368 694 3,119 2.0 Performance Based Restricted Stock 107 140 1,079 2.8 Performance Based Options 45 53 226 1.5 Total $ 612 $ 1,068 $ 5,051 June 30, 2015 Incentive Stock Options $ 116 $ 231 $ 1,204 2.5 Restricted Stock 790 1,962 3,521 1.5 Performance Based Restricted Stock 107 205 811 2.0 Performance Based Options 45 87 454 2.5 Total $ 1,058 $ 2,485 $ 5,990
Summary of Option Activity	Option activity within each plan is as follows: Incentive Weighted Average Exercisable Balance outstanding, December 31, 2015 626,845 $ 9.25 $ 7.73 Options exercised (25,500 ) 7.50 Options forfeited (9,813 ) 11.49 Balance outstanding, March 31, 2016 591,532 $ 9.29 $ 7.84 Options exercised (12,900 ) 7.50 Options forfeited (5,000 ) 11.49 Balance outstanding, June 30, 2016 573,632 $ 9.31 $ 7.85
Summary of Stock Options Summarized by Exercise Price	Information relating to stock options at June 30, 2016 summarized by exercise price is as follows: Outstanding Weighted Average Exercisable Weighted Exercise Price Per Share Shares Remaining Exercise Shares Exercise Incentive Stock Option Plan: $7.50 318,850 53 $ 7.50 318,850 $ 7.50 $11.32—$14.49 254,782 98 $ 11.57 25,507 $ 12.28 573,632 $ 9.31 344,357 $ 7.85
Weighted Average Exercise Prices for Options Granted and Exercisable and Weighted Average Remaining Contractual Life for Options Outstanding	The weighted average exercise prices for options granted and exercisable and the weighted average remaining contractual life for options outstanding as of June 30, 2016 was as follows: Number Weighted Weighted Intrinsic As of June 30, 2016: Incentive Stock Option Plans: Outstanding 573,632 $ 9.31 73 $ 3,329 Expected to Vest 565,767 $ 9.28 73 $ 3,300 Exercisable 344,357 $ 7.85 54 $ 2,499
Performance Based Options
Summary of Option Activity	Performance based option activity is as follows: Incentive Weighted Average Exercisable Balance outstanding, December 31, 2015 98,410 $ 11.49 $ — Options forfeited (8,946 ) 11.49 — Balance outstanding, March 31, 2016 89,464 $ 11.49 $ — Balance outstanding, June 30, 2016 89,464 $ 11.49 $ —
Summary of Stock Options Summarized by Exercise Price	Information relating to outstanding stock options at June 30, 2016 summarized by exercise price is as follows: Outstanding Weighted Average Exercisable Weighted Exercise Price Per Share Shares Remaining Exercise Shares Exercise Performance Incentive Stock Option Plan: $11.49 89,464 18 $ 11.49 — $ — 89,464 $ 11.49 — $ —
Weighted Average Exercise Prices for Options Granted and Exercisable and Weighted Average Remaining Contractual Life for Options Outstanding	The weighted average exercise prices for options granted and exercisable and the weighted average remaining contractual life for options outstanding as of June 30, 2016 are as follows: Number Weighted Weighted Intrinsic As of June 30, 2016: Incentive Stock Option Plans: Outstanding 89,464 $ 11.49 18 $ 324 Expected to Vest 81,546 $ 11.49 18 $ 295 Exercisable — $ — — $ —
Restricted Stock
Summary of Non-Vested Shares	Restricted Shares — Six Months Ended Six Months Ended Number Weighted Number Weighted Nonvested shares at January 1 st 362,841 $ 20.43 560,842 $ 21.44 Granted — — 30,000 11.42 Vested (127,274 ) 31.29 (192,266 ) 20.47 Forfeited (16,008 ) 23.67 (422 ) 14.92 Nonvested shares at March 31 st 219,559 $ 14.59 398,154 $ 21.17 Granted 140,541 $ 15.08 21,005 $ 14.28 Vested (22,639 ) 15.63 (28,505 ) 13.53 Forfeited (6,457 ) 14.98 (1,201 ) 14.92 Nonvested shares at June 30 th 331,004 $ 14.72 389,453 $ 21.37
Performance Based Restricted Stock
Summary of Non-Vested Shares	Performance Based Restricted Shares — Six Months Ended Six Months Ended Number Weighted Number Weighted Nonvested shares at January 1 st 104,403 $ 17.05 103,907 $ 17.77 Granted — — 7,500 10.96 Forfeited (9,395 ) 17.65 — — Nonvested shares at March 31 st 95,008 $ 16.99 111,407 $ 17.31 Granted 52,170 14.39 — — Forfeited (19,612 ) 28.25 — — Nonvested shares at June 30 th 127,566 $ 14.20 111,407 $ 17.31

Accumulated Other Comprehensi34

Accumulated Other Comprehensive Income ("AOCI") (Tables)	6 Months Ended
	Jun. 30, 2016
Beginning Balance, Annual Activity and Ending Balance of Accumulated Other Comprehensive Gain (Loss) of Foreign Currency Translation Adjustments	The following table lists the beginning balance, annual activity and ending balance of accumulated other comprehensive gain (loss), which consists of foreign currency translation adjustments: For the Six Months Ended June 30, 2016 Balance, December 31, 2015 $ (3,541 ) Other comprehensive gain 85 Balance, March 31, 2016 $ (3,456 ) Other comprehensive loss (537 ) Balance, June 30, 2016 $ (3,993 ) For the Six Months Ended June 30, 2015 Balance, December 31, 2014 $ (1,970 ) Other comprehensive loss (248 ) Balance, March 31, 2015 $ (2,218 ) Other comprehensive loss (323 ) Balance, June 30, 2015 $ (2,541 )

Summary of Property, Plant and

Summary of Property, Plant and Equipment (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Property, Plant and Equipment [Line Items]
Property, plant and equipment, Gross	$ 141,195	$ 139,591
Less accumulated depreciation	(95,807)	(91,619)
Total Property, plant and equipment	45,388	47,972
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment, Gross	2,458	2,458
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, Gross	15,020	14,726
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, Gross	116,928	113,506
Office furniture, fixtures and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, Gross	4,947	4,997
Automotive equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, Gross	508	491
Construction in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, Gross	$ 1,334	$ 3,413

Property, Plant And Equipment -

Property, Plant And Equipment - Additional Information (Detail) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Property, Plant and Equipment [Line Items]
Depreciation expense related to property, plant and equipment	$ 4,313	$ 4,531
Elimination of Assets and Accumulated depreciation	$ 125	$ 231

Components of Inventories (Deta

Components of Inventories (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Inventory [Line Items]
Finished products	$ 131,946	$ 120,456
Raw materials	19,156	16,021
Total Inventories	$ 151,102	$ 136,477

Segment Reporting - Additional

Segment Reporting - Additional Information (Detail)	6 Months Ended
	Jun. 30, 2016Segment
Number of reportable business segments	1

Summary of Business Sales Segme

Summary of Business Sales Segmentation as per Product (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Net Sales:
Total crop	$ 58,336	$ 57,792	$ 119,605	$ 117,313
Non-crop	14,388	8,731	22,593	15,775
Net sales	72,724	66,523	142,198	133,088
Insecticides
Net Sales:
Total crop	30,912	27,586	64,018	61,945
Herbicides/Soil Fumigants/Fungicides
Net Sales:
Total crop	21,093	17,451	45,767	39,291
Other, Including Plant Growth Regulators
Net Sales:
Total crop	$ 6,331	$ 12,755	$ 9,820	$ 16,077

Summary of Business Sales Seg40

Summary of Business Sales Segmentation as per Location (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Net Sales:
Net sales	$ 72,724	$ 66,523	$ 142,198	$ 133,088
US
Net Sales:
Net sales	51,773	43,842	101,628	93,064
International
Net Sales:
Net sales	$ 20,951	$ 22,681	$ 40,570	$ 40,024

Cash Dividend (Detail)

Cash Dividend (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Mar. 31, 2015	Jun. 30, 2016
Dividends [Line Items]
Cash dividend declaration date	Mar. 16, 2015	Dec. 11, 2014	Jun. 13, 2016
Cash dividend record date	Apr. 3, 2015	Dec. 26, 2014	Jun. 30, 2016
Cash dividend distributed date	Apr. 17, 2015	Jan. 9, 2015	Jul. 12, 2016
Cash dividend per share	$ 0.02	$ 0.02	$ 0.01
Cash dividend paid	$ 572	$ 569	$ 289

Components of Basic and Diluted

Components of Basic and Diluted Earnings Per Share (Detail) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Numerator:
Net income attributable to AVD	$ 3,246	$ 781	$ 6,040	$ 832
Denominator:
Weighted average shares outstanding-basic	28,893	28,676	28,851	28,602
Dilutive effect of stock options and grants	484	526	491	501
Weighted average shares outstanding-assuming dilution	29,377	29,202	29,342	29,103

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Detail) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Components Of Basic And Diluted Earning Per Share [Line Items]
Stock options excluded from computation of diluted earning per share	0	0	0	0

Summary Revolving Line of Credi

Summary Revolving Line of Credit And Various Notes Payable Constitute Short-Term and Long-Term Loan Balances Together (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Extinguishment of Debt [Line Items]
Revolving line of credit, Long Term	$ 50,150	$ 69,000
Revolving line of credit, Short-term	0	0
Revolving line of credit	50,150	69,000
Deferred loan fees, Long Term	(574)	(679)
Deferred loan fees, Short-term	0	0
Deferred loan fees	(574)	(679)
Notes payable, Long Term	0	0
Notes payable, Short-term	18	55
Notes payable	18	55
Long Term debt	49,576	68,321
Short-term	18	55
Total indebtedness	$ 49,594	$ 68,376

Indebtedness - Additional Infor

Indebtedness - Additional Information (Detail) - USD ($)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Debt Instrument [Line Items]
Available borrowings capacity under credit agreement		$ 27,101,000
Senior secured credit facility term	5 years
Senior secured credit facility, maturity date	Jun. 17, 2018
Maximum
Debt Instrument [Line Items]
Capacity to increase borrowings under credit agreement	$ 92,588,000
Revolving Line of Credit
Debt Instrument [Line Items]
Available borrowings capacity under credit agreement	200,000,000
Term Loan | Maximum
Debt Instrument [Line Items]
Accordion feature	$ 100,000,000

Unamortized Stock-Based Compens

Unamortized Stock-Based Compensation Expenses (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	$ 612	$ 1,058	$ 1,068	$ 2,485
Unamortized Stock-Based Compensation	5,051	5,990	5,051	5,990
Incentive Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	92	116	181	231
Unamortized Stock-Based Compensation related to stock options	627	1,204	$ 627	$ 1,204
Remaining Weighted Average Period (years)			1 year 6 months	2 years 6 months
Performance Based Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	45	45	$ 53	$ 87
Unamortized Stock-Based Compensation related to stock options	226	454	$ 226	$ 454
Remaining Weighted Average Period (years)			1 year 6 months	2 years 6 months
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	368	790	$ 694	$ 1,962
Unamortized Stock-Based Compensation other than options	3,119	3,521	$ 3,119	$ 3,521
Remaining Weighted Average Period (years)			2 years	1 year 6 months
Performance Based Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	107	107	$ 140	$ 205
Unamortized Stock-Based Compensation other than options	$ 1,079	$ 811	$ 1,079	$ 811
Remaining Weighted Average Period (years)			2 years 9 months 18 days	2 years

Stock Based Compensation - Addi

Stock Based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2015	Mar. 31, 2015	Jun. 30, 2016	Jun. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employees options granted					0
Stock-based compensation	$ 612		$ 1,058		$ 1,068	$ 2,485
Performance Based Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	45		45		53	87
Nonvested unamortized stock-based compensation expense, value	226				$ 226
Nonvested unamortized stock-based compensation expense, contractual term					1 year 6 months
Incentive Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	92		116		$ 181	231
Nonvested unamortized stock-based compensation expense, value	627		1,204		$ 627	$ 1,204
Nonvested unamortized stock-based compensation expense, contractual term					1 year 6 months	2 years 6 months
Performance Based Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	$ 107		107		$ 140	$ 205
Nonvested unamortized stock-based compensation expense, contractual term					2 years 9 months 18 days	2 years
Number of shares granted to employees	52,170			7,500	52,170	7,500
Weighted Average Grant-Date Fair Value, Granted	$ 14.39			$ 10.96
Unamortized Stock-Based Compensation other than options	$ 1,079		$ 811		$ 1,079	$ 811
Cliff vesting date						Jan. 5, 2018
Targeted performance percentage	200.00%		200.00%		200.00%	200.00%
Performance Based Restricted Stock | Performance Based Shares Related to Net Income Weighted at 50%, Net Sales Weighted at 30%, Commencing January 1, 2016 and Ending December 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Grant-Date Fair Value, Granted					$ 15.08
Performance Based Restricted Stock | Remaining 20% of Performance Based Shares are Based Upon AVD Stock Price Appreciation for the Period Commencing January 1, 2016 and Ending December 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Grant-Date Fair Value, Granted					$ 11.63
Performance Based Restricted Stock | Vested on January 6, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cliff vesting date					Jan. 6, 2019
Performance Based Restricted Stock | Performance Based Shares Based Upon Financial Performance of Earnings before Interest Tax ("EBIT") and Net Sales Goal for the Period Commencing January 1, 2016 and Ending December 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares vesting based on Performance					80.00%	80.00%
Earnings before income tax goal weight, percentage					50.00%	50.00%
Net sales goal weight, percentage					30.00%	30.00%
Performance Based Restricted Stock | Performance Based Shares Based Upon AVD Stock Price Appreciation Over the Course of the Period Commencing January 1, 2016, Ending December 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares vesting based on Performance					20.00%	20.00%
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	$ 368		$ 790		$ 694	$ 1,962
Nonvested unamortized stock-based compensation expense, contractual term					2 years	1 year 6 months
Number of shares granted to employees	140,541		21,005	30,000	140,541	51,005
Number of Shares, Vested	22,639	127,274	28,505	192,266
Number of years of service before cliff vesting					3 years	3 years
Weighted Average Grant-Date Fair Value, Granted	$ 15.08		$ 14.28	$ 11.42	$ 15.08	$ 12.60
Unamortized Stock-Based Compensation other than options	$ 3,119		$ 3,521		$ 3,119	$ 3,521
Restricted Stock | Vest after 90 days
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Vested						7,500
Restricted Stock | Vested immediately
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Vested					21,139	21,005
Restricted Stock | Vest after three years
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Vested					119,402

Summary of Option Activity (Det

Summary of Option Activity (Detail) - $ / shares	3 Months Ended
	Jun. 30, 2016	Mar. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Incentive Stock Option Plans, Beginning balance	591,532	626,845
Incentive Stock Option Plans, Option exercised	(12,900)	(25,500)
Incentive Stock Option Plans, Option forfeited	(5,000)	(9,813)
Incentive Stock Option Plans, Ending balance	573,632	591,532
Weighted Average Price Per Share, Beginning balance	$ 9.29	$ 9.25
Weighted Average Price Per Share, Option exercised	7.50	7.50
Weighted Average Price Per Share, Option forfeited	11.49	11.49
Weighted Average Price Per Share, Ending balance	9.31	9.29
Exercisable Weighted Average Price Per Share, Beginning balance	7.84	7.73
Exercisable Weighted Average Price Per Share, Ending balance	$ 7.85	$ 7.84
Performance Based Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Incentive Stock Option Plans, Beginning balance	89,464	98,410
Incentive Stock Option Plans, Option forfeited		(8,946)
Incentive Stock Option Plans, Ending balance	89,464	89,464
Weighted Average Price Per Share, Beginning balance	$ 11.49	$ 11.49
Weighted Average Price Per Share, Option forfeited		11.49
Weighted Average Price Per Share, Ending balance	$ 11.49	$ 11.49

Summary of Stock Options Summar

Summary of Stock Options Summarized by Exercise Price (Detail) - $ / shares	6 Months Ended
	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Weighted Average, Exercise Price	$ 9.31	$ 9.29	$ 9.25
Exercisable Weighted Average, Exercise Price	$ 7.85	7.84	7.73
Incentive Stock Option Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Weighted Average, Shares	573,632
Outstanding Weighted Average, Remaining Life (Months)	73 months
Outstanding Weighted Average, Exercise Price	$ 9.31
Exercisable Weighted Average, Shares	344,357
Exercisable Weighted Average, Exercise Price	$ 7.85
Incentive Stock Option Plan | Range One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Price Per Share, Lower Range	$ 7.50
Outstanding Weighted Average, Shares	318,850
Outstanding Weighted Average, Remaining Life (Months)	53 months
Outstanding Weighted Average, Exercise Price	$ 7.50
Exercisable Weighted Average, Shares	318,850
Exercisable Weighted Average, Exercise Price	$ 7.50
Incentive Stock Option Plan | Range Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Price Per Share, Lower Range	11.32
Exercise Price Per Share, Upper Range	$ 14.49
Outstanding Weighted Average, Shares	254,782
Outstanding Weighted Average, Remaining Life (Months)	98 months
Outstanding Weighted Average, Exercise Price	$ 11.57
Exercisable Weighted Average, Shares	25,507
Exercisable Weighted Average, Exercise Price	$ 12.28
Performance Based Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Weighted Average, Shares	89,464
Outstanding Weighted Average, Remaining Life (Months)	18 months
Outstanding Weighted Average, Exercise Price	$ 11.49	$ 11.49	$ 11.49
Performance Based Stock Options | Range Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Price Per Share, Lower Range	$ 11.49
Outstanding Weighted Average, Shares	89,464
Outstanding Weighted Average, Remaining Life (Months)	18 months
Outstanding Weighted Average, Exercise Price	$ 11.49

Weighted Average Exercise Price

Weighted Average Exercise Prices for Options Granted and Exercisable and Weighted Average Remaining Contractual Life for Options Outstanding (Detail) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Outstanding	573,632	591,532	626,845
Weighted Average Exercise Price, Outstanding	$ 9.31	$ 9.29	$ 9.25
Weighted Average Exercisable, Exercise Price	$ 7.85	$ 7.84	$ 7.73
Incentive Stock Option Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Outstanding	573,632
Number of Shares, Expected to Vest	565,767
Number of Shares, Exercisable	344,357
Weighted Average Exercise Price, Outstanding	$ 9.31
Weighted Average Exercise Price, Expected to Vest	9.28
Weighted Average Exercisable, Exercise Price	$ 7.85
Weighted Average Remaining Life, Outstanding	73 months
Weighted Average Remaining Contractual Life, Expected to Vest	73 months
Weighted Average Remaining Contractual Life, Exercisable	54 months
Intrinsic Value, Outstanding	$ 3,329
Intrinsic Value, Expected to Vest	3,300
Intrinsic Value, Exercisable	$ 2,499
Performance Based Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Outstanding	89,464	89,464	98,410
Number of Shares, Expected to Vest	81,546
Weighted Average Exercise Price, Outstanding	$ 11.49	$ 11.49	$ 11.49
Weighted Average Exercise Price, Expected to Vest	$ 11.49
Weighted Average Remaining Life, Outstanding	18 months
Weighted Average Remaining Contractual Life, Expected to Vest	18 months
Intrinsic Value, Outstanding	$ 324
Intrinsic Value, Expected to Vest	$ 295

Summary of Non-Vested Shares (D

Summary of Non-Vested Shares (Detail) - Restricted Stock - $ / shares	3 Months Ended				6 Months Ended
	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2015	Mar. 31, 2015	Jun. 30, 2016	Jun. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Beginning balance	219,559	362,841	398,154	560,842	362,841	560,842
Number of Shares, Granted	140,541		21,005	30,000	140,541	51,005
Number of Shares, Vested	(22,639)	(127,274)	(28,505)	(192,266)
Number of Shares, Forfeited	(6,457)	(16,008)	(1,201)	(422)
Number of Shares, Ending Balance	331,004	219,559	389,453	398,154	331,004	389,453
Weighted Average Grant-Date Fair Value, Beginning balance	$ 14.59	$ 20.43	$ 21.17	$ 21.44	$ 20.43	$ 21.44
Weighted Average Grant-Date Fair Value, Granted	15.08		14.28	11.42	15.08	12.60
Weighted Average Grant-Date Fair Value, Vested	15.63	31.29	13.53	20.47
Weighted Average Grant-Date Fair Value, Forfeited	14.98	23.67	14.92	14.92
Weighted Average Grant-Date Fair Value, Ending balance	$ 14.72	$ 14.59	$ 21.37	$ 21.17	$ 14.72	$ 21.37

Status Summary of Non-Vested Sh

Status Summary of Non-Vested Shares (Detail) - Performance Based Restricted Stock - $ / shares	3 Months Ended				6 Months Ended
	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2015	Mar. 31, 2015	Jun. 30, 2016	Jun. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Beginning balance	95,008	104,403	111,407	103,907	104,403	103,907
Number of Shares, Granted	52,170			7,500	52,170	7,500
Number of Shares, Forfeited	(19,612)	(9,395)
Number of Shares, Ending Balance	127,566	95,008	111,407	111,407	127,566	111,407
Weighted Average Grant-Date Fair Value, Beginning balance	$ 16.99	$ 17.05	$ 17.31	$ 17.77	$ 17.05	$ 17.77
Weighted Average Grant-Date Fair Value, Granted	14.39			10.96
Weighted Average Grant-Date Fair Value, Forfeited	28.25	17.65
Weighted Average Grant-Date Fair Value, Ending balance	$ 14.20	$ 16.99	$ 17.31	$ 17.31	$ 14.20	$ 17.31

Litigation and Environmental -

Litigation and Environmental - Additional Information (Detail) - USD ($) $ in Millions	May 12, 2015	Jun. 30, 2016
Schiemer Farms Matter
Loss Contingencies [Line Items]
Settlement agreement date		Apr. 25, 2016
Alleged loss of yield	$ 1.2
Navarro Matter
Loss Contingencies [Line Items]
Settlement agreement date		Apr. 30, 2016

Beginning Balance, Annual Activ

Beginning Balance, Annual Activity and Ending Balance of Accumulated Other Comprehensive Income Gain (Loss) (Detail) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2015	Mar. 31, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance	$ 271,534	$ 268,326
Other comprehensive gain (loss)	(537)	85	$ (323)	$ (248)
Balance	274,834	271,534
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance	(3,456)	(3,541)	(2,218)	(1,970)
Balance	$ (3,993)	$ (3,456)	$ (2,541)	$ (2,218)

Equity Method Investment - Addi

Equity Method Investment - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Equity Method Investments [Line Items]
Gain loss from equity method investment			$ (129)	$ (191)
TyraTech Inc.
Equity Method Investments [Line Items]
Equity investment ownership position	15.11%		15.11%
Gain loss from equity method investment	$ (47)	$ (191)	$ (129)	$ (191)
Carrying value of equity investment	2,407		2,407
Quoted market value of equity investment	$ 2,324		$ 2,324

Equity Investment - Additional

Equity Investment - Additional Information (Detail) - Bi-PA	6 Months Ended
	Jun. 30, 2016USD ($)
Schedule of Cost-method Investments [Line Items]
Cost method ownership percentage	15.00%
Cost-method Investments, Impairment	$ 0

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Income Taxes [Line Items]
Income taxes (benefit) expense	$ 1,203	$ (393)	$ 2,263	$ (685)
Effective tax rate			25.90%	339.10%

Subsequent Event - Additional I

Subsequent Event - Additional Information (Detail)	Aug. 02, 2016
Subsequent Event | Huifeng/AMVAC Innovation Co., Ltd.
Subsequent Event [Line Items]
Percentage of ownership on joint venture by subsidiary	50.00%